Active substance
Methenamine
- US FDA 8
- US price lines 3
- NHS prices 1
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| UREX | 1GM | tablet · oral | QUAGEN | Prescription | 5 Jul 1967 |
| HIPREX | 1GM | tablet · oral | ESJAY PHARMA | Prescription | 9 Sep 1976 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 5 Jul 2016 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | MICRO LABS | Prescription | 1 Aug 2019 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | INGENUS PHARMS LLC | Prescription | 27 Nov 2020 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | JUBILANT CADISTA | Prescription | 1 Dec 2023 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 10 Mar 2025 |
| METHENAMINE HIPPURATE | 1GM | tablet · oral | IMPAX LABS INC | Discontinued | 20 Jun 2003 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | METHENAMINE HIPP 1 GM TABLET | $0.31261 | per EA | 30 Sep 2026 |
| US NADAC | METHENAMINE MAND 1 GM TABLET | $2.60435 | per EA | 23 Sep 2026 |
| US NADAC | METHENAMINE MAND 500 MG TABLET | $1.36088 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Methenamine hippurate 1g tablets | £32.21 | 60 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 1 Dec 2017 HIPREX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions
Combinations containing Methenamine
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.